Outsourcing

Articles

The companies form a strategic joint venture for developing and manufacturing live biotherapeutics.

Lonza and Chr. Hansen in Joint Venture to Accelerate Momentum in Microbiome

Pharmaceutical Technology and BioPharm International will present a Keynote Session on Meeting Bioprocessing Manufacturing Capacity Demands on Wednesday, April 3, 2019, during INTERPHEX 2019 at the Javits Center in New York City.

Biologic Drug Manufacturing Capacity on the Agenda for INTERPHEX 2019 Keynote Series

Rita Peters is the former editorial director of 

Pharmaceutical Technology, Pharmaceutical Technology Europe

Supplier vetting and monitoring-plus comprehensive testing-ensure quality of raw materials.

Locking Fraudulent Materials Out of the Supply Chain

Michael Jovanis is vice-president of Vault Quality, Veeva Systems, jovanis@veeva.com.

Moving from paper-based to digitalized processes is the first step to enabling quality management and manufacturing to work in sync.

Digitizing to Modernize Manufacturing

Belgium-based CDMO MaSTherCell will expand its European manufacturing capacity for cell and gene therapy products by setting up a new facility in Belgium. 

MaSTherCell Announces New Commercial Manufacturing Facility for Cell and Gene Therapies

Walter Colasante is a vice-president in Charles River Associates’ (CRA’s) Life Sciences Practice. 

Pascale Diesel is a vice-president in Charles River Associates’ (CRA’s) Life Sciences Practice.

Think ahead to production requirements when planning strategies in early development of gene and cell therapies.

The Link Between Manufacturing and Commercialization in Gene and Cell Therapy

The companies aim to assess automated CAR-T cell therapy manufacturing at the point-of-care and develop technologies to facilitate patient access to immunotherapies.

Lonza, Sheba to Collaborate on Automated Cell-Therapy Manufacturing

The Pharma Services business of Thermo Fisher Scientific will invest $150 Million at three facilities.

Thermo Fisher Scientific Adds Aseptic Capacity

Alcami Biologics formed to meet market demands for biological drug development services.

Alcami Announces Biologics Enterprise

Catalent announces investment for its Zydis ODT technology, offering increased drug load and taste-masking capabilities.

Contract Manufacturing Services